Carolina Alvadia
About Carolina Alvadia
Carolina Alvadia is a Membrane Protein Scientist currently employed at Exscientia in Oxford since 2021. She has a strong academic background, holding a PhD in Biochemistry from the University of Zurich and a Master's degree in Molecular Biosciences from the University of Oslo.
Work at Exscientia
Carolina Alvadia has been employed at Exscientia as a Membrane Protein Scientist since 2021. Her role involves research and development related to membrane proteins, contributing to the company's focus on artificial intelligence-driven drug discovery. Exscientia is known for its innovative approach in the pharmaceutical industry, and Alvadia's expertise in membrane proteins supports the company's mission to enhance drug design and development processes.
Education and Expertise
Carolina Alvadia holds a Doctor of Philosophy (PhD) in Biochemistry from the University of Zurich, which she completed between 2016 and 2021. Prior to her PhD, she earned a Master of Science (MSc) in Molecular Biosciences with a focus on Molecular Biology from the University of Oslo, studying from 2013 to 2015. She also obtained a Bachelor of Science (BSc) in Genetics and Biotechnology from Universidade de Trás-os-Montes e Alto Douro, completing her studies in 2013. Her educational background provides a strong foundation in molecular biology and biochemistry.
Background
Carolina Alvadia began her academic journey at Universidade de Trás-os-Montes e Alto Douro, where she studied Genetics and Biotechnology from 2010 to 2013. Following her undergraduate studies, she pursued a Master's degree at the University of Oslo from 2013 to 2015. After completing her Master's, she worked as a Master's student at the Centre for Molecular Medicine Norway (NCMM) at the University of Oslo for one year. She then continued her education at the University of Zurich, where she completed her PhD in Biochemistry from 2016 to 2021.
Previous Experience
Before her current position at Exscientia, Carolina Alvadia gained valuable experience as a PhD student at the University of Zurich from 2016 to 2021. She also worked at the Centre for Molecular Medicine Norway (NCMM) as a Master's student from 2014 to 2015. Earlier in her career, she completed a Bachelor's thesis at UTAD for one month in 2012. This diverse experience across various institutions has contributed to her expertise in membrane proteins and molecular biology.